Characterization of Early Markers of Choroidal Neovascularization
CNV-Markers
CNV-Markers
Sponsor study identifier
observational
60
1 country
1
Study Start
December 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2008
Actual (reported)Study Completion
June 2014
Actual (reported)To this study and identify the sequence of alterations occurring in the chorioretinal interface during progression of AMD from "dry" AMD to sight-threatening chorioretinal neovascularization (CNV).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2014
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2005
Date type not reportedThis date has not been verified as actual or estimated.
December 2008
Actual (reported)December 2, 2008
Actual (reported)December 3, 2008
Actual (reported)June 2014
Actual (reported)Wet AMD development in the study eye.
Single Visit
Patients with wet AMD in one eye and dry AMD in the other eye (study eye).
Patients of either sex, any race, aged over 50 years and over, diagnosed with exudative (wet) AMD in one eye (non-study eye) and non-exudative (dry) AMD (intermediate or large/confluent drusen, with hyperpigmentation, and no CNV or geographic atrophy) in the other eye (study eye) that is at risk for progressing to exudative (wet) AMD and meet all the inclusion and exclusion criteria.
AIBILI - Clinical Trial Center
Coimbra, Coimbra District, 3000-548, Portugal
Marques JP, Costa M, Melo P, Oliveira CM, Pires I, Cachulo ML, Figueira J, Silva R. Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System. ISRN Ophthalmol. 2013 Jul 30;2013:464218. doi: 10.1155/2013/464218. eCollection 2013.
José Cunha-Vaz, MD PhD
Association for Innovation and Biomedical Research on Light and Image
60 participants (actual enrollment reported by the registry).
First Submitted
December 2, 2008
First Posted
December 3, 2008
Study Start
December 2005
Date type not reportedThis date has not been verified as actual or estimated.
PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)
Contact the study team to confirm eligibility.
Primary Completion
December 2008
Actual (reported)Study Completion
June 2014
Actual (reported)Last Updated
March 19, 2015
Record last verified: 2014-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: